loading

Marinus Pharmaceuticals Inc 주식(MRNS)의 최신 뉴스

pulisher
Jun 09, 2025

MRNS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Marinus Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Jun 09, 2025
pulisher
Jun 06, 2025

Investors who lost money on Marinus Pharmaceuticals, Inc. (MRNS) should contact Levi & Korsinsky about pending Class ActionMRNS - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 02, 2025

Shareholders that lost money on Marinus Pharmaceuticals, Inc.(MRNS) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

Jun 02, 2025
pulisher
May 23, 2025

Marinus Pharmaceuticals (NASDAQ:MRNS) Coverage Initiated at Wall Street Zen - Defense World

May 23, 2025
pulisher
May 21, 2025

CDKL5 Deficiency Disorder Market Expected to Experience Major - openPR.com

May 21, 2025
pulisher
May 21, 2025

UPCOMING MRNS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Marinus Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

May 21, 2025
pulisher
May 14, 2025

Shareholders that Lost Money on Marinus Pharmaceuticals, Inc. (MRNS) Should Contact Levi & Korsinsky About Pending Class ActionMRNS - ACCESS Newswire

May 14, 2025
pulisher
May 13, 2025

Marinus Pharmaceuticals (NASDAQ:MRNS) Now Covered by Analysts at StockNews.com - Defense World

May 13, 2025
pulisher
May 13, 2025

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives Consensus Rating of “Hold” from Analysts - Defense World

May 13, 2025
pulisher
May 12, 2025

Can The RAISE Study Data Give Marinus' Stock A Boost? - RTTNews

May 12, 2025
pulisher
May 10, 2025

FINAL MRNS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Marinus Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

May 10, 2025
pulisher
May 05, 2025

StockNews.com Begins Coverage on Marinus Pharmaceuticals (NASDAQ:MRNS) - Defense World

May 05, 2025
pulisher
May 04, 2025

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Shares Sold by Geode Capital Management LLC - Defense World

May 04, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 26, 2025

Lost Money on Marinus Pharmaceuticals, Inc.(MRNS)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 19, 2025

StockNews.com Initiates Coverage on Marinus Pharmaceuticals (NASDAQ:MRNS) - Defense World

Apr 19, 2025
pulisher
Apr 14, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Marinus Pharmaceuticals, Inc.(MRNS) Shareholders - ACCESS Newswire

Apr 14, 2025
pulisher
Apr 11, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Marinus Pharmaceuticals, Inc. (MRNS) Shareholders - ACCESS Newswire

Apr 11, 2025
pulisher
Apr 06, 2025

Kiniksa Pharmaceuticals (NASDAQ:KNSA) versus Marinus Pharmaceuticals (NASDAQ:MRNS) Financial Analysis - Defense World

Apr 06, 2025
pulisher
Apr 03, 2025

Fragile X Syndrome Market to Show Remarkable Growth Trends from - openPR.com

Apr 03, 2025
pulisher
Apr 03, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Marinus - MarketScreener

Apr 03, 2025
pulisher
Apr 01, 2025

Marinus pharmaceuticals director sells shares for $864 - MSN

Apr 01, 2025
pulisher
Mar 27, 2025

Status Epilepticus Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight | Marinus Pharma, Pfizer, UCB Biopharma SRL, Sage Therapeutics, Shire - The Globe and Mail

Mar 27, 2025
pulisher
Mar 26, 2025

Dravet Syndrome Market Expected to Experience Major Growth - openPR.com

Mar 26, 2025
pulisher
Mar 21, 2025

Refractory Status Epilepticus Treatment Market Size in 7MM - openPR.com

Mar 21, 2025
pulisher
Mar 20, 2025

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Business Wire

Mar 20, 2025
pulisher
Mar 20, 2025

Developmental and Epileptic Encephalopathies Treatment - openPR.com

Mar 20, 2025
pulisher
Mar 07, 2025

Intra-Cellular deal, Axsome settlement drive neurological index recovery - BioWorld MedTech

Mar 07, 2025
pulisher
Mar 02, 2025

Marinus Pharmaceuticals (NASDAQ:MRNS) Now Covered by StockNews.com - Armenian Reporter

Mar 02, 2025
pulisher
Feb 27, 2025

MRNS LAWSUIT ALERT: Levi & Korsinsky Notifies Marinus Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 26, 2025

Levi & Korsinsky Notifies Marinus Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMRNS - ACCESS Newswire

Feb 26, 2025
pulisher
Feb 26, 2025

Long-Term Investors in Marinus Pharmaceuticals, Inc. (NASDAQ: - openPR

Feb 26, 2025
pulisher
Feb 21, 2025

Class Action Filed Against Marinus Pharmaceuticals, Inc. (MRNS) Seeking Recovery for Investors – Contact Levi & Korsinsky - ACCESS Newswire

Feb 21, 2025
pulisher
Feb 20, 2025

Marinus Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Feb 20, 2025
pulisher
Feb 20, 2025

Class Action Filed Against Marinus Pharmaceuticals, Inc. (MRNS) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

Feb 20, 2025
pulisher
Feb 17, 2025

Marinus Pharmaceuticals director sells shares worth $869 - MSN

Feb 17, 2025
pulisher
Feb 17, 2025

Marinus Pharmaceuticals CEO Scott Braunstein sells $167,530 in stock - MSN

Feb 17, 2025
pulisher
Feb 17, 2025

Tuberous Sclerosis Complex Therapeutics Market Size Report - openPR

Feb 17, 2025
pulisher
Feb 15, 2025

IMMINENT MRNS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Marinus Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Feb 15, 2025
pulisher
Feb 14, 2025

Marinus Pharmaceuticals (NASDAQ:MRNS) Coverage Initiated at StockNews.com - Defense World

Feb 14, 2025
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):